1. Home
  2. ALIT vs CDXS Comparison

ALIT vs CDXS Comparison

Compare ALIT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alight Inc.

ALIT

Alight Inc.

HOLD

Current Price

$0.79

Market Cap

270.4M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.51

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALIT
CDXS
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
270.4M
256.3M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ALIT
CDXS
Price
$0.79
$2.51
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$3.75
N/A
AVG Volume (30 Days)
21.3M
1.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
21.33%
N/A
EPS Growth
N/A
43.82
EPS
N/A
N/A
Revenue
$2,262,000,000.00
$138,590,000.00
Revenue This Year
N/A
$7.73
Revenue Next Year
$0.14
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$0.48
$0.96
52 Week High
$6.03
$3.87

Technical Indicators

Market Signals
Indicator
ALIT
CDXS
Relative Strength Index (RSI) 51.84 51.17
Support Level $0.65 $2.40
Resistance Level $1.00 $2.67
Average True Range (ATR) 0.10 0.22
MACD 0.01 -0.06
Stochastic Oscillator 36.89 5.77

Price Performance

Historical Comparison
ALIT
CDXS

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: